- Industry Size (2022)
- USD 2.1 Bn
- Forecast (2032)
- USD 3.5 Bn
- CAGR
- 6% to 7% (2022 to 2032)
Diagnostic Stopper Market Outlook (2022-2032)
[250 Pages Report] The demand in the global diagnostic stopper market is expected to reach US$ 2.1 Bn by 2022, exhibiting growth at a CAGR of 6% to 7% during the forecast period from 2022 to 2032. The sales of diagnostic stoppers are estimated to surpass a valuation of US$ 3.4 Bn by the end of 2032, as comparied to the US$ 1.9 Bn registered in the year 2021.
| Report Attribute | Details |
| Diagnostic Stopper Market Base Year Value (2021) | US$ 1.9 Billion |
| Diagnostic Stopper Market Expected Value (2022) | US$ 2.1 Billion |
| Diagnostic Stopper Market Anticipated Value (2032) | US$ 3.5 Billion |
| Diagnostic Stopper Market Projected Growth Rate (2022-2032) | 6% to 7% CAGR |
Diagnostic stoppers, also known as sterile rubber stoppers, are medical products used to provide contaminant-free protection to the medical and pharmaceutical containers such as ampoules, vials, and others. These stoppers are generally used for storing lyophilized and liquid products and for providing leakage-proof seals to penicillin bottles and antibiotic bottles.
What are the Leading Factors Creating Growth Opportunities in the Global Diagnostic Stopper Market?
Diagnostic stoppers are garnering huge popularity across pharmaceutical, chemical, and medical industries, owing to their ability to provide an excellent barrier against moisture, gases, and ultraviolet (UV) rays, which is in turn, accelerating the sales in the global market.
A number of governmental and regulatory organizations across the world such as the Food & Drug Organization, International Organization for Standardization, and others are implementing stringent regulations for sterilization of liquids for safe and germ-free drug delivery.
Attributed to this, a significant rise in adoption of gamma irradiation and autoclaving processes is being witnessed for sterilized sealing across pharmaceutical and healthcare industry players. As diagnostic stoppers are used for sealing medical and pharmaceutical containers with liquid products during aforementioned processes, a slew of such sterilization norms and standards are projected to augment the demand in the global market.
What are the Major Constraints Faced by the Global Diagnostic Stopper Market?
Although there are a number of advantages related to the use of diagnostic stoppers, volatility in the cost of raw material, high cost of these rubber stoppers, and increasing availability of closures alternatives are some factors hindering the growth in the market,
Also, implementation of strict regulations regards the use of teflon coating used on diagnostic stoppers, owing to its adverse impact on environment is estimated to hamper the sales in the market.
Why is the Demand for Diagnostic Stopper Accelerating in the North America Market?
As per FMI, North America is projected to register growth at a rapid CAGR in the global diagnostic stopper market during the forecast period 2022-2032.
With growing awareness regarding proper sanitization during drug maintenance and transportation, demand for sterilized diagnostic stoppers is surging at a robust pace. Hence, key companies in the market are emphasizing on introducing novel products to capitalize on the increasing demand.
For instance, DWK Life Sciences, a U.S.-based manufacturer of laboratory glass, rubber, and plastic consumables, announced launching a novel product of Duran branded synthetic rubber stopper, GL45, especially designed for the efficient sealing of laboratory glass bottles. A multiplicity of such new product launches is estimated to bolster the sales in the North America market.
What are the Growth Prospects for Diagnostic Stopper in the South Asia Market?
South Asia is expected to account for a significant share in the global diagnostic stopper market from 2022 to 2032, states Future Market Insights.
Due to the rising prevalence of diseases and swift expansion of the pharmaceutical industry in Asia Pacific, a significant surge in demand for therapeutics liquid drugs such as penicillin and antibiotic is witnessed across the countries such as India, China, and South Korea among others.
Hence, leading industry players are focusing on expanding their production capacity to cater to this growing demand, which is in turn, increasing the sales of ampoules, vials, and other pharmaceutical containers. As diagnostic stoppers are used to seal these packaging containers, such developments are anticipated to propel the demand in the South Asia market.
Market Competition
Some of the leading players in the diagnostic stopper market are Adelphi Group, APG Pharma, SciLabware Ltd., West Pharmaceutical Services, Inc., VWR International, LLC., DWK Life Sciences Inc., and others.
The market for diagnostic stopper is highly competitive, attributed to growing adoption of new product launch, collaboration, partnership, mergers & acquisitions strategies by leading players.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 6% to 7% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2015-2020 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Countries Covered |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Diagnostic Stopper Market Survey
By Product Type:
- Sleeve Stopper
- Straight Plug Stopper
- Snap On Stopper
- Conical Stopper
- 3Leg Stopper
By Material:
- Butyl Rubber
- Chlorobutyl
- Bromobutyl
- EPDM
- Natural Rubber
- Nitrile
- Silicon
By Coating:
- B2 Coating
- Flurotech & Teflon Coating
By Sterilization Technology:
- Autoclavable
- Gamma Irradiation
By Diameter Size:
- 13mm
- 20mm
- 28mm
- 32mm
By Application:
- Injection Stopper
- Infusion Stopper
By End Use:
- Pharmaceutical
- Medical & Healthcare
- Chemical
- Research & Development
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
What is the sales forecast for diagnostic stopper in the global market until 2032?
FMI projects the sales of diagnostic stopper in the market is expected to rise at 6% to 7% value CAGR by 2032.
Which region is forecast to be the most lucrative for diagnostic stopper market growth?
The global diagnostic stopper market is expected to be dominated by the North America over forecast period 2022-2032.
Which are some leading diagnostic stopper manufacturers?
Adelphi Group, APG Pharma, SciLabware Ltd., West Pharmaceutical Services, Inc., VWR International, LLC., DWK Life Sciences Inc., and others are some of the leading players in the prominent diagnostic stopper market.
Preview the report firsthand - request a free sample
Get SampleGet the brochure for pricing and purchase details.
Get PDFTable of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Diagnostic Stopper Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2022-2032
5.3.1. 13mm
5.3.2. 20mm
5.3.3. 28mm
5.3.4. 32mm
5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Type, 2022-2032
6. Global Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022-2032
6.3.1. Pharmaceutical Industry
6.3.2. Chemical Industry
6.3.3. Healthcare Industry
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Chile
9.2.1.5. Peru
9.2.1.6. Rest of Latin America
9.2.2. By Type
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.4. Key Takeaways
10. Europe Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Type
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.4. Key Takeaways
11. Asia Pacific Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Rest of Asia Pacific
11.2.2. By Type
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Application
11.4. Key Takeaways
12. Middle East and Africa Diagnostic Stopper Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Turkey
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Type
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Application
12.4. Key Takeaways
13. Key Countries Diagnostic Stopper Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Type
13.1.2.2. By Application
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Type
13.2.2.2. By Application
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Type
13.3.2.2. By Application
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Type
13.4.2.2. By Application
13.5. Argentina
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Type
13.5.2.2. By Application
13.6. Chile
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Type
13.6.2.2. By Application
13.7. Peru
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Type
13.7.2.2. By Application
13.8. Germany
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Type
13.8.2.2. By Application
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Type
13.9.2.2. By Application
13.10. France
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Type
13.10.2.2. By Application
13.11. U.K.
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Type
13.11.2.2. By Application
13.12. Spain
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Type
13.12.2.2. By Application
13.13. Russia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Type
13.13.2.2. By Application
13.14. BENELUX
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Type
13.14.2.2. By Application
13.15. China
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Type
13.15.2.2. By Application
13.16. Japan
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Type
13.16.2.2. By Application
13.17. South Korea
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Type
13.17.2.2. By Application
13.18. GCC Countries
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Type
13.18.2.2. By Application
13.19. South Africa
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Type
13.19.2.2. By Application
13.20. Turkey
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Type
13.20.2.2. By Application
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Type
14.3.3. By Application
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Adelphi Group
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. APG Pharma
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. DWK Life Sciences
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. West Pharmaceutical Services
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. SciLabware
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodolog
